NCT06106906View on ClinicalTrials.gov

A Clinical Study of CD19 CAR-T in Active Systemic Lupus Erythematosus

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

June 19, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2027

Conditions
Systemic Lupus Erythematosus
Interventions
BIOLOGICAL

CD19 CAR-T cell infusion

CD19 CAR-T cell intravenous infusion

Trial Locations (1)

430022

RECRUITING

Wuhan Union Hospital, Wuhan

All Listed Sponsors
collaborator

Guangzhou Bio-gene Technology Co., Ltd

INDUSTRY

lead

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

OTHER